ferent preventive strategies used comparable risk estimates but different cost calculations and reached different conclusions. Two studies 3, 4 stated that universal recto-vaginal culture at 26 to 28 weeks for group B streptococcus (GBS) and intrapartum treatment of culture-positive high-risk patients in labor was cost effective. A third study z questioned this and concluded that presently either universal treatment during labor, or treatment based on risk factors, or treatment based on preterm delivery and 36-week culture stats would be the most effective strategies.
A disadvantage of decision analysis is that the influence of contributing factors is based on research performed some time earlier, while the weight of these factors may well be modified by other changes of management than antibiotic prophylaxis or by technical improvements in neonatal care. Ideally a comparison of different strategies for prevention of early-onset GBS infection should be performed by a randomized trial. Unfortunately, such studies are not feasible due to the low incidence of early-onset GBS infection and consequently the extremely large number of patients that would be required. 5 Furthermore, most studies of preventive strategies for early-onset GBS infection do not take other causes of neonatal sepsis into account. It is not known presently whether the incidence of neonatal sepsis caused by other organisms is influenced positively or negatively by these strategies. The endpoint of our study is, therefore, not only early-onset GBS infection but also neonatal sepsis of other origin. The purpose of the study is to evaluate a change of management regarding the diagnosis and treatment of women with early signs of intrauterine infection during labor. The hypothesis of this new strategy was that most serious sequelae and death would result from intrauterine onset of early-onset GBS infection, while colonization and onset of infection after delivery would be recognized more easily and could therefore be treated in a more timely manner. The most important factor influencing the incidence of early-onset GBS sepsis is maternal carrier rate. This figure varies largely from 4% to 40% (usually 20-30%), depending on ethnic origin, culture site, and the use of selective culture media. 8 In the Netherlands a carrier rate during labor of 19% was reported by selective culture of rectum and introitus. 9 In our own hospital in 1992 GBS was cultured selectively from rectum and introitus in 41 (27%) of 150 women during labor. Carrier rate in the Netherlands seems to be comparable to many other countries.
SUBJECTS AND METHODS
The incidence of early onset GBS sepsis is 0.7-3.7/1,000, depending on geographic area. 8 The incidence in our population is rather high compared to this figure due to the high incidence of preterm deliveries (19%) in our tertiary care center as a result of the referral system in the Netherlands. Our results demonstrated that early detection of clinical signs of intrauterine infection and early antibiotic treatment resulted in a statistically significant decrease of early-onset GBS infection and reduced the serious sequelae of this infection without large-scale antibiotic administration. Notwithstanding a reduction of early-onset GBS infection the incidence of sepsis caused by other organisms remained unchanged. We should be aware that the prophylactic measures that we take against early-onset GBS infection might result in an increase of sepsis caused by other pathogens. Institutions which adopted antibiotic chemoprophylaxis not only should report on reduced incidence of early-onset GBS infection, but also should register all cases of neonatal sepsis and possible changes of antibiotic resistance of the organisms involved.
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